TY - JOUR
T1 - Older Adults' Perspectives on Clinical Research
T2 - A Focus Group and Survey Study
AU - Lenze, Eric J.
AU - Ramsey, Alex
AU - Brown, Patrick J.
AU - Reynolds, Charles F.
AU - Mulsant, Benoit H.
AU - Lavretsky, Helen
AU - Roose, Steven P.
N1 - Funding Information:
This study was supported primarily by the National Institute of Mental Health ( R01 MH083660 and P30 MH90333 to University of Pittsburgh, R01 MH083648 to Washington University, R01 MH083643 to University of Toronto, and K23 MH099097 and T32 MH20004 to Columbia University and New York State Psychiatric Institute). Additional funding was provided by the UPMC Endowment in Geriatric Psychiatry , the Taylor Family Institute for Innovative Psychiatric Research (at Washington University), the Washington University Institute of Clinical and Translational Sciences , grant UL1 TR000448 from the National Center for Advancing Translational Sciences (NCATS), and the Campbell Family Mental Health Research Institute at the Centre for Addiction and Mental Health , Toronto. These funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.
Publisher Copyright:
© 2016 American Association for Geriatric Psychiatry
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Objectives Clinical trials can benefit from patient perspectives to inform trial design, such as choice of outcome measures. We engaged older adults in focus groups and surveys to get their perspective regarding needs in clinical research. The goal was to inform the development of a new clinical trial of medication strategies for treatment-resistant depression in older adults. Methods Older adults with depression participated in focus groups and a subsequent survey in St. Louis and New York. They were queried regarding research design features including outcomes, clinical management, mobile technology and iPad-administered assessments, the collection of DNA, and the receipt of their personal results. Results Patients told us: (1) psychological well-being and symptomatic remission are outcomes that matter to them; (2) it is important to measure not only benefits but risks (such as risk of falling) of medications; (3) for pragmatic trials in clinical settings, the research team should provide support to clinicians to ensure that medications are properly prescribed; (4) technology-based assessments are acceptable but there were concerns about data security and burden; (5) DNA testing is very important if it could improve precision care; (6) participants want to receive aggregate findings and their own personal results at the end of the study. Conclusions Patients gave useful and wide-ranging guidance regarding clinical and comparative effectiveness research in older adults. We discuss these findings with the goal of making the next generation of geriatric studies more impactful and patient-centered.
AB - Objectives Clinical trials can benefit from patient perspectives to inform trial design, such as choice of outcome measures. We engaged older adults in focus groups and surveys to get their perspective regarding needs in clinical research. The goal was to inform the development of a new clinical trial of medication strategies for treatment-resistant depression in older adults. Methods Older adults with depression participated in focus groups and a subsequent survey in St. Louis and New York. They were queried regarding research design features including outcomes, clinical management, mobile technology and iPad-administered assessments, the collection of DNA, and the receipt of their personal results. Results Patients told us: (1) psychological well-being and symptomatic remission are outcomes that matter to them; (2) it is important to measure not only benefits but risks (such as risk of falling) of medications; (3) for pragmatic trials in clinical settings, the research team should provide support to clinicians to ensure that medications are properly prescribed; (4) technology-based assessments are acceptable but there were concerns about data security and burden; (5) DNA testing is very important if it could improve precision care; (6) participants want to receive aggregate findings and their own personal results at the end of the study. Conclusions Patients gave useful and wide-ranging guidance regarding clinical and comparative effectiveness research in older adults. We discuss these findings with the goal of making the next generation of geriatric studies more impactful and patient-centered.
KW - antidepressant
KW - older adults
KW - patient perspectives
KW - treatment-resistant depression
UR - http://www.scopus.com/inward/record.url?scp=84994908932&partnerID=8YFLogxK
U2 - 10.1016/j.jagp.2016.07.022
DO - 10.1016/j.jagp.2016.07.022
M3 - Article
C2 - 27591916
AN - SCOPUS:84994908932
VL - 24
SP - 893
EP - 902
JO - American Journal of Geriatric Psychiatry
JF - American Journal of Geriatric Psychiatry
SN - 1064-7481
IS - 10
ER -